Usage and Plan of Care Changes Due to Drug Screenings

Pain Management Clinical Trial

Official title:

Clinical Researcher Experience Assessment Documenting Usage and Plan of Care Changes Due to Drug Screenings ©

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT02995278
• Other study ID #: PAS1459
• Status: Enrolling by invitation
• Start date: October 2016
• Est. completion date: October 2020

Study information

• Verified date: January 2019
• Source: Data Collection Analysis Business Management
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this minimal risk, observational survey is to document the accuracy, benefits, and how qualitative and quantitative results affect patients' plan of care.

Description:

Pain is the most common reason patients consult primary care providers. According to recent surveys, One in six Americans live with chronic or recurrent pain and pay an estimated $120 billion a year in medical costs in the United States. Oral opioids are the common treatment options for various chronic pains including joint pain, musculoskeletal pain, neuropathic pain and migraines. This narcotic-based management of pain is often associated with undesirable side effects with addictive and potential abuse.

To ensure proper usage of prescribed medications, physicians use drug screens to monitor therapeutic levels and test for presence of illegal drugs or medications that may cause a drug-drug interaction. Upon receiving quantitative or qualitative results from these drug screens, the physician may change the treatment plan for patients to improve efficacy of prescribed medications.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 2000
• Est. completion date: October 2020
• Est. primary completion date: October 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

• Must be a Medical Practioner

• Medical Doctor (MD)

• Doctor of Osteopathic (DO)

• Physician Assistant (PA)

• Advanced Practice Registered Nurse (APRN)

• Nurse Practioner (NP)

• Must have a current standard operating procedure that includes obtaining/reviewing medical history.

Exclusion Criteria:

• Government-funded insurance data cannot be included in the study.

Related Conditions & MeSH terms

• Pain Management

Intervention

Other:
• Does not include a drug needing FDA approval and therefore it is not by definition, a Clinical Drug Trial as defined by FDA.

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Data Collection Analysis Business Management	PAS Research Services

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Plan of Care Changes due to Drug Screenings	Provider based observational survey	3 years